Anna Kempisty

ORCID: 0000-0003-1546-7968
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sarcoidosis and Beryllium Toxicity Research
  • Tuberculosis Research and Epidemiology
  • Infectious Diseases and Tuberculosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Mycobacterium research and diagnosis
  • Transplantation: Methods and Outcomes
  • Infectious Diseases and Mycology
  • Vitamin D Research Studies
  • Vasculitis and related conditions
  • Radiopharmaceutical Chemistry and Applications
  • Lung Cancer Diagnosis and Treatment
  • Occupational exposure and asthma
  • Osteomyelitis and Bone Disorders Research
  • Atomic and Subatomic Physics Research
  • Bone health and treatments
  • Diagnosis and treatment of tuberculosis
  • Eosinophilic Disorders and Syndromes
  • Pleural and Pulmonary Diseases
  • Fibroblast Growth Factor Research
  • Quinazolinone synthesis and applications
  • Pneumothorax, Barotrauma, Emphysema

Medical University of Warsaw
2019

Instytut Gruźlicy i Chorób Płuc
2008-2016

Masih Daneshvari Hospital
2015

National Institute of Public Health
2013

Sarcoidosis is a systemic granulomatous disease which predominantly affects the lungs, although granulomas can also involve all other organs, including heart. Cardiac sarcoidosis (CS) may occur at any stage of and be cause sudden cardiac death, even in previously asymptomatic patient. The aim this study was to evaluate incidence CS large group patients diagnosed or followed up due sarcoidosis.We performed retrospective analysis our institution discharged with final diagnosis "sarcoidosis"...

10.1007/s00408-015-9805-8 article EN cc-by Lung 2015-09-28

Introduction: This study is a part of the project on interferon gamma release assays performed in group untreated sarcoidosis patients formerly BCG vaccinated. The aim was to assess rate positive commercial γ patients. We discussed results context hypothesis that M. tuberculosis antigens may play role pathogenesis sarcoidosis. Material and Methods: 151 patients, mean age 38 ± 10.3, treatment naive, with newly diagnosed pulmonary were enrolled into study. All participants underwent QFT-GIT...

10.5603/piap.2015.0020 article EN Advances in respiratory medicine 2015-03-10

Abstract Dyspnea and exercise intolerance are usually attributed to pulmonary disease in sarcoidosis patients. However, cardiac involvement may also be responsible for these symptoms. Data regarding the impact of heart on lung function (CS) is limited. The aim study was compare results tests (PFTs) patients with without involvement. We performed a retrospective analysis PFTs group both evaluated by cardiovascular magnetic resonance (CMR) study. period between May 2008 April 2016. included...

10.1097/md.0000000000018037 article EN cc-by-nc Medicine 2019-11-01

Cancers are one of the risk factors non-tuberculous mycobacterial (NTM) lung disease. The majority data in this group patients concern infections caused by Mycobacterium avium-the most prevalent NTM species worldwide. In contrast, limited information can be found regarding uncommon such as szulgai. We present case M. szulgai disease a patient with history breast cancer. Coexistence and cancer metastasis well primary was suspected. Finally, neoplastic ruled out based on negative results...

10.3390/antibiotics9080482 article EN cc-by Antibiotics 2020-08-05

<b>Background:</b> Lung function and exercise performance in sarcoidosis are affected by both, lung cardiac involvement. Data regarding the impact of heart involvement on (CS) is limited. The aim this study was to assess compare results spirometry, volumes, transfer factor for carbon monoxide (TL,CO) six-minute walking test (6MWT) patients with without <b>Methods:</b> A retrospective analysis pulmonary tests 6MWT group biopsy-proven detected or excluded cardiovascular magnetic resonance...

10.1183/13993003.congress-2018.pa5216 article EN 2018-09-15

<b>Introduction:</b> Diagnosis of sarcoidosis relies on properly conducted differential diagnosis disorders with similar clinical and histopathological features. Exclusion active tuberculosis during is not equal to exclusion latent infection (LTBI). In patients, this aspect particularly important in those who are going be treated immunosuppressive drugs. patients sarcoidosis, the use IGRAs detection LTBI may have a limited specifity, as has been shown studies based molecular immunological...

10.1183/13993003.congress-2015.pa3315 article EN 2015-09-01

<b>Introduction:</b> Tuberculin skin test (TST) is one of the recommended in initial evaluation patients suspected for sarcoidosis and most have negative TST results. At present, an alterative to are tests based on measurement interferon gamma release by sensitized T lymphocytes response stimulation antigens specific <i>M.tuberculosis</i> (IGRAs). In many countries IGRAs replaced detection latent tuberculosis infection (LTBI). The role still unknown. <b>Object rationale:</b> aim this study...

10.1183/13993003.congress-2015.pa833 article EN 2015-09-01

Zaburzenia gospodarki wapniowej w przebiegu sarkoidozy pod postacią hiperkalcemii lub/i hiperkalciurii mogą u niektórych chorych powodować uszkodzenie nerek. Zagrażająca życiu hiperkalcemia nie jest zjawiskiem częstym na sarkoidozę. Niewydolność nerek spowodowana ciężką hiperkalcemią zdarza się rzadko. W pracy zaprezentowano przypadek 53-letniego mężczyzny przyjętego do Kliniki Chorób Płuc z powodu objawów zespołu hiperkalcemicznego i niewydolności nerek, którego rozpoznano Zastosowanie...

10.5603/arm.27540 article PL Advances in respiratory medicine 2012-10-29

<b>Introduction:</b> The majority of patients with sarcoidosis are under pulmonologists care. proper diagnostic work-up involves not only the respiratory system. Assessment extrapulmonary organ involvement is an important element at time diagnosis, but also during further follow-up. Neurosarcoidosis potentially dangerous and affects prognosis disease. <b>Aim:</b> To assess prevalence neurological symptoms in pulmonary analysis causes. <b>Method:</b> Retrospective database hospitalized 1st...

10.1183/1393003.congress-2017.pa3264 article EN 2017-09-01

Patients after organ transplantations are at risk for mycobacteriosis development. Frequency of the mycobacterial infection bone marrow transplantation (BMT) is not as high one could expect. It ranges from 0.4 to 4.9%. We present a case female patient allogenic BMT treatment chronic myelogenous leucaemia, with bronchiolitis obliterans symptom graft versus host disease (GvHD), treated corticosteroids and infected Mycobacterium avium. She was admitted hospital dyspnoea, cough large amount...

10.5603/arm.27916 article EN Advances in respiratory medicine 2008-04-28
Coming Soon ...